University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Octaplas®

Alternative to Factor XI when it is unavailable

Status: Green Octenisan nasal gel

Where allergy to Bactroban® exists or there are supply issues with Bactroban®

Status: Red Octreotide (Sandostatin LAR®) injection

Amber - palliative care use only

Red - Oncology, acromegaly

Status: Amber Octreotide injection

For gastroenterology use - initiation by specialist

Status: Red Octreotide injection

Amber - palliative care use only

Red - Oncology, acromegaly

Status: Red Ofatumumab

For hospital use only

Status: Amber Olanzapine orodispersible tablets

Specialist initiation only, ESCA

Status: Amber Olanzapine tablets

Specialist initiation only, ESCA

Status: Red Olaratumab

For hospital use only

Status: Green Olopatadine (Opatanol®)

Second line - high relative cost.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top